14 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in the event of a security incident. These types of mandatory disclosures are costly, could lead to negative publicity, and may cause our partners to lose
ARS
1uv 0vv532wjmhice
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
EX-1.2
59bh73u5h5fx
10 Nov 21
Automatic shelf registration
5:19pm
S-1
EX-10.14
xy4 0kewg
10 Sep 20
IPO registration
5:26pm
S-1
EX-3.4
yzcsr67b1wwi09ih9z
10 Sep 20
IPO registration
5:26pm
DRS
EX-3.3
8m7klli4
6 Aug 20
Draft registration statement
12:00am
DRS
EX-10.9
8mu4i0 u5gi6
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next